Empowered Patient Podcast

Mike Wenger, Vice President of Patient Engagement, TrialScope is thinking about ways to improve the clinical trials process by focusing more on the patients that are being recruited, tracked and retained. We talk about the need to overcome challenges of enrollment, helping patients find the right clinical trial, and reducing the costs related to the time-consuming process of conducting clinical trials.

@TrialScope

TrialScope.com

Listen to the podcast here

Mike Wenger, Vice President of Patient Engagement, TrialScope is thinking about ways to improve the clinical trials process by focusing more on the patients that are being recruited, tracked and retained. We talk about the need to overcome challenges of enrollment, helping patients find the right clinical trial, and reducing the costs related to the time-consuming process of conducting clinical trials.

@TrialScope

TrialScope.com

Read the transcript here

Anish Suri, President and Chief Scientific Officer, Cue Biopharma discusses their proprietary Immuno-STAT(tm) platform. Cue Biopharma is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer and autoimmune diseases. The company's proprietary platform Immuno-STAT(tm) (Selective Targeting and Alteration of T cells) is designed to harness the body's intrinsic immune system without the need for ex vivo manipulation. The company is currently conducting a Phase 1 study in HPV16-driven head and neck cancer and partnering with Merck to develop treatments for autoimmune diseases.

@cuebiopharma

#immunooncology #HNSCC #TCells

CueBiopharma.com

Listen to the podcast here

Anish Suri, President and Chief Scientific Officer, Cue Biopharma discusses their proprietary Immuno-STAT(tm) platform. Cue Biopharma is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body to transform the treatment of cancer and autoimmune diseases. The company's proprietary platform Immuno-STAT(tm) (Selective Targeting and Alteration of T cells) is designed to harness the body's intrinsic immune system without the need for ex vivo manipulation. The company is currently conducting a Phase 1 study in HPV16-driven head and neck cancer and partnering with Merck to develop treatments for autoimmune diseases.

@CueBiopharma

#immunooncology #HNSCC #TCells

CueBiopharma.com

Download the transcript here

Dr. Igor Grant, Director, Center for Medicinal Cannabis Research at the University of California San Diego talks about the need for basic science studies on new indications and promises of cannabinoids, potential medical effects of both THC and CBD, the uptick in funding for clinical studies, relative safety of cannabis compared to other drugs, and which diseases and chronic conditions are currently being effectively treated with some form of cannabis.

CMCR.UCSD.edu

Listen to the podcast here

Dr. Igor Grant, Director, Center for Medicinal Cannabis Research at the University of California San Diego talks about the need for basic science studies on new indications and promises of cannabinoids, potential medical effects of both THC and CBD, the uptick in funding for clinical studies, relative safety of cannabis compared to other drugs, and which diseases and chronic conditions are currently being effectively treated with some form of cannabis.

CMCR.UCSD.edu

Download the transcript here

Dr. Mark Scholz, author and medical oncologist specializes in prostate cancer and he is determined to change the way the most common cancer in men is being diagnosed and treated. Currently, prostate cancer is the only cancer treatment managed by a surgeon and not an oncologist, reflecting the days when the only answer was for the urologist to operate. Publishing a self-administered test and providing information about alternative treatments and side-effects, Mark is eager to change the way patients and doctors attack this disease.

#prostatecancer #cancer #oncology

ProstateOncology.com

PCRI.org

Listen to the podcast here

Dr. Mark Scholz, author and medical oncologist specializes in prostate cancer and he is determined to change the way the most common cancer in men is being diagnosed and treated. Currently, prostate cancer is the only cancer treatment managed by a surgeon and not an oncologist, reflecting the days when the only answer was for the urologist to operate. Publishing a self-administered test and providing information about alternative treatments and side-effects, Mark is eager to change the way patients and doctors attack this disease.

#prostatecancer #cancer #oncology

ProstateOncology.com

PCRI.org

Download the transcript here

Dr. Andrea Trescot, Chief Medical Officer, Stimwave has focused on pain for many years and she shares her passion for the latest innovations in stimulating the spinal column to provide a rapid treatment for chronic pain and provide an effective alternative to opioids. With innovations in miniaturization, batteries, and wireless interfaces, Stimwave is expanding the pain targets to include peripheral nerve stimulation to address such conditions as osteoarthritis of the knee and chronic facial pain.

@ stimwave

#neurostimulation #neuromodulation #ChronicPain #opioids

Stimwave.com

Listen to the podcast here

Dr. Andrea Trescot, Chief Medical Officer, Stimwave has focused on pain for many years and she shares her passion for the latest innovations in stimulating the spinal column to provide a rapid treatment for chronic pain and provide an effective alternative to opioids. With innovations in miniaturization, batteries, and wireless interfaces, Stimwave is expanding the pain targets to include peripheral nerve stimulation to address such conditions as osteoarthritis of the knee and chronic facial pain.

@ stimwave

#neurostimulation #neuromodulation #ChronicPain #opioids

Stimwave.com

Download the transcript here